Heart failure due to aorto-right atrial fistula and successful treatment with percutaneous closure

Anar Mammadli1, Mustafa Kılıçkap, İrem Dinçer

  • 1Department of Cardiology, Ankara University Faculty of Medicine, Ankara, Turkey. drmammadli@yahoo.com.

Insights

A rare aorto-right atrial fistula was successfully closed using a minimally invasive percutaneous device. This intervention significantly improved the patient's heart function and reduced symptoms like ascites.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Aorto-atrial fistula is a rare cardiac anomaly, often resulting from acquired conditions like endocarditis, dissection, or postsurgical complications.
  • Patients may present with symptoms of heart failure, including dyspnea and ascites, leading to significant functional impairment.

Observation:

  • A 50-year-old female with a history of cardiac surgery and heart failure presented with severe dyspnea and ascites (NYHA class III).
  • Physical examination revealed a systolic murmur, ascites, and hepatomegaly.
  • Diagnostic imaging, including echocardiography and aortography, confirmed an aorto-right atrial fistula.

Findings:

  • Percutaneous closure of the aorto-right atrial fistula was performed using an Amplatzer Duct Occluder II device due to high surgical risk.
  • The patient experienced a rapid and dramatic improvement in symptoms, with reduced ascites and diuretic requirements within one week.
  • Functional capacity improved to NYHA class II, and right atrial pressure normalized within one month post-procedure.

Implications:

  • Percutaneous closure offers a safe and effective alternative for managing aorto-atrial fistulas in high-risk patients.
  • Minimally invasive techniques can lead to rapid symptom relief and functional recovery.
  • Successful fistula closure can significantly improve outcomes for patients with complex cardiac conditions.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
907
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
877
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
332
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963